The only FDA-Approved treatment for Lysosomal Acid Lipase Deficiency (LAL-D)
KANUMA® (sebelipase alfa) is a prescription medication used to treat people with a diagnosis of LAL-D.
Keep Me Updated
Get the latest news and information about KANUMA and LAL-D.
Kanuma® (sebelipase alfa) is administered via infusion
KANUMA is indicated for the treatment of people with a diagnosis of LAL-D and is administered as an infusion by a healthcare professional.
For more information on KANUMA infusions:
Download Infusion Brochure
Getting Started on Kanuma
KANUMA is indicated for the treatment of patients with a diagnosis of LAL-D. Once your doctor has determined that KANUMA is right for you, sign up for OneSource™, and personalized patient support program from Alexion Pharmaceuticals.
There are 2 ways to get access to OneSource:
Get in touch with a OneSource nurse case manager.
Download the OneSource enrollment form below
Print this form, sign it, and submit it to OneSource. Someone will be in touch within the next business day.
Submit via email: KanumaOneSource@alxn.com
Submit via fax: 1-781-240-8003
Download OneSource enrollment form
KANUMA support by OneSource
Once your doctor has decided that KANUMA is right for you, OneSource is here to help. Alexion’s objective is that every person living with LAL-D who can benefit from KANUMA will have access to it. After signing up, you will be matched with a dedicated Alexion nurse case manager who can help answer any questions you may have about KANUMA or LAL-D.
OneSource is staffed by Alexion nurse case managers who provide one-to-one education, information on funding options and access to KANUMA, and ongoing treatment support for people living with LAL-D, and their caregivers.